Christoph von Muellern

Director
Cristoph von Muellern | European Competition | Charles River Associates

Christoph von Muellern is a Director in the Brussels Office of CRA’s European Competition Practice. For more than a decade, he has advised clients on all aspects of competition policy before the European Commission, national competition authorities, and national courts.

Christoph has an extensive track record in guiding clients through complex national and multi-jurisdictional merger control proceedings. He has advised on more than 20 merger cases, with recent examples including SLB’s $7.8 billion acquisition of ChampionX, Novo Holdings’ $16.5 billion acquisition of Catalent, and Allison Transmission’s $2.7 billion acquisition of Dana’s Off-Highway Business. His merger experience spans a wide range of industries, including automotive supply, oilfield services, chemicals, semi-finished copper products, cement, telecommunications, printers, fast-moving consumer goods (FMCG), pharmaceuticals, medical devices, waste processing, and container handling.

He also brings strong expertise in conducting empirical and theoretical economic analyses in complex regulatory proceedings. His work includes advising leading technology companies on abuse of dominance investigations by the European Commission and national regulators, as well as on tech regulations such as the Digital Markets Act (DMA).

Christoph also has significant experience in cartel litigation, where he has quantified damages and provided economic advice in high-profile cases across sectors such as automotive components, sugar, trucks, beer, car shipping, and wood.

Prior to joining CRA, Christoph worked for more than five years in the Brussels office of a German-based economic consultancy specialized in competition policy. He holds a Master of Science in Economics from the Humboldt University Berlin.

Selected engagements

  • 01
    EC unconditionally approves $16.5bn acquisition of Catalent by Novo Holdings
    By providing additional fill-finish capacity, the transaction would enable Novo Nordisk to reach more obesity and diabetes patients faster. The Commission...
    View engagement
  • 02
    European Commission unconditionally approves INEOS’ acquisition of certain assets of TotalEnergies
    On March 13, 2024, the European Commission unconditionally approved INEOS’ acquisition of sole control of certain assets of TotalEnergies in France in Phase...
    View engagement
  • 03
    European Commission closes investigations into retail alliances
    On 13 July 2023, the European Commission announced its decision to close its preliminary investigations into certain practices of two European retail...
    View engagement

Credentials

Get In Touch